↓ Skip to main content

A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer

Overview of attention for article published in BMC Cancer, June 2009
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
41 Dimensions

Readers on

mendeley
178 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer
Published in
BMC Cancer, June 2009
DOI 10.1186/1471-2407-9-210
Pubmed ID
Authors

Robert U Newton, Dennis R Taaffe, Nigel Spry, Robert A Gardiner, Gregory Levin, Bradley Wall, David Joseph, Suzanne K Chambers, Daniel A Galvão

Abstract

Androgen deprivation therapy (ADT) is accompanied by a number of adverse side effects including reduced bone mass and increased risk for fracture, reduced lean mass and muscle strength, mood disturbance and increased fat mass compromising physical functioning, independence, and quality of life. The purpose of this investigation is to examine the effects of long term exercise on reversing musculoskeletal-related side effects, and cardiovascular and diabetes risk factors in men receiving androgen deprivation for their prostate cancer. Specifically, we aim to investigate the effects of a 12-month exercise program designed to load the musculoskeletal system and reduce cardiovascular and diabetes disease progression on the following primary endpoints: 1) bone mineral density; 2) cardiorespiratory function and maximal oxygen capacity; 3) body composition (lean mass and fat mass); 4) blood pressure and cardiovascular function; 5) lipids and glycemic control; and 6) quality of life and psychological distress.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 178 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 2 1%
United Kingdom 1 <1%
Denmark 1 <1%
Spain 1 <1%
Unknown 173 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 33 19%
Student > Ph. D. Student 23 13%
Researcher 22 12%
Student > Bachelor 19 11%
Student > Postgraduate 15 8%
Other 31 17%
Unknown 35 20%
Readers by discipline Count As %
Medicine and Dentistry 50 28%
Sports and Recreations 27 15%
Nursing and Health Professions 14 8%
Agricultural and Biological Sciences 9 5%
Psychology 8 4%
Other 28 16%
Unknown 42 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 June 2012.
All research outputs
#18,308,895
of 22,668,244 outputs
Outputs from BMC Cancer
#5,415
of 8,243 outputs
Outputs of similar age
#101,730
of 110,507 outputs
Outputs of similar age from BMC Cancer
#47
of 49 outputs
Altmetric has tracked 22,668,244 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,243 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 21st percentile – i.e., 21% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 110,507 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 3rd percentile – i.e., 3% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one is in the 2nd percentile – i.e., 2% of its contemporaries scored the same or lower than it.